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Abstract
Summary This study evaluated the characteristics of patients
with vertebral fractures and examined the discriminative
ability of clinical risk factors. The findings provide further
insights into possible development of a simple, cost-effective
scheme for fracture risk assessment using clinical risk factors
to identify high-risk patients for further evaluation.
Introduction Vertebral fractures are the most common
complication of osteoporosis. The aim of this study was
to evaluate the characteristics of patients with vertebral
fractures and to determine the discriminative ability of bone
mineral density (BMD) and other clinical risk factors.
Methods Postmenopausal Southern Chinese women (2,178)
enrolled in the Hong Kong Osteoporosis Study since 1995
were prospectively followed up for fracture outcome. Subjects
(1,372) with lateral spine radiographs were included in this
study. Baseline demographic, BMD, and clinical risk factor
information were obtained from a structured questionnaire.
Results Subjects (299; 22%) had prevalent vertebral fractures.
The prevalence of vertebral fractures increased with increas-
ing age, number of clinical risk factors, and decreasing BMD.
The odds of having a prevalent vertebral fracture per SD
reduction in BMD after adjustment for age in Hong Kong
Southern Chinese postmenopausal women was 1.5 for the
lumbar spine and femoral neck. Analysis of the receiver
operating characteristic curve revealed that bone mineral
apparent density did not enhance fracture risk prediction.
Subjects with ≥4 clinical risk factors had 2.3-fold higher odds
of having a prevalent vertebral fracture while subjects with ≥4
clinical risk factors plus a low BMD (i.e., femoral neck T-
score <−2.5) had 2.6-fold. Addition of BMD to clinical risk
factors did not enhance the discriminative ability to identify
subjects with vertebral fracture.
Conclusions Based on these findings, we recommend that
screening efforts should focus on older postmenopausal
women with multiple risk factors to identify women who
are likely to have a prevalent vertebral fracture.
Keywords Ethnicity . Osteoporosis . Prevalence .
Southern Chinese . Vertebral fracture
Introduction
Osteoporosis is a disease associated with decreased bone
mass and bone strength and leads to increased fracture risk.
Due to its high prevalence worldwide [1], osteoporosis has
become a major public health concern. The epidemiology
of hip fractures has been intensively studied over the past
few decades because of its expensive treatment cost and
adverse outcomes. Although hip fractures are less prevalent
in Asians [2], vertebral fractures are as frequent in Asian as
in Caucasian women [3–5]. Indeed, vertebral fractures are
the most common complication of osteoporosis, accounting
for nearly 50% of all osteoporotic fractures [6]. Besides
physical deformity, vertebral fracture is associated with
reduced mobility and quality of life [7, 8], and increased
mortality [9, 10]. Previous studies have shown that
vertebral fracture often occurs earlier than hip fractures in
disease progression and that vertebral fracture is associated
with an increased risk of both future vertebral and
nonvertebral fractures [11–14]. Therefore, characterizing
the prevalence of vertebral deformities and associated
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clinical risk factors would help physicians and policy-
makers to determine the appropriate amount of emphasis to
be placed on diagnosis and prevention of osteoporosis.
Although vertebral fractures are important as an indepen-
dent risk factor for further fracture, they are not easy to
diagnose as it has been estimated that only 30% of vertebral
fractures come to medical attention [15]. Additionally, preva-
lence of vertebral fractures tends to vary across ethnic groups
and geographic regions [6]. For example, studies in Europe
have shown that the prevalence of vertebral fractures was
higher in the UK [15] and Denmark [16] and lower in Finland
[17]. On the contrary, in instances in which comparable
methods and definitions have been used in studies, the
prevalence of morphometric or radiographic vertebral frac-
tures has been more similar across regions [5, 18, 19]. Taken
together, compared with hip fractures, the epidemiology of
vertebral fractures is less well established, especially in Asia.
In this study, we evaluated the clinical profile in Southern
Chinese postmenopausal women with vertebral fracture and
examined for clinical risk factors and possible ethnic
difference associated with vertebral fracture in this population.
Methods
Study population
This is a part of the Hong Kong Osteoporosis Study
(HKOS), in which 2,178 community-based postmenopausal
women (defined as at least 1 year has passed their last
menstrual cycle) who were ≥45 years of age were recruited
from health fairs held in various districts in Hong Kong for
identification of genetic and environmental risk factors for
osteoporosis and fractures [20, 21]. Participants who
received anti-osteoporosis treatment and/or postmenopausal
hormonal replacement therapy were excluded from analy-
sis. For the present study, 1,372 (63%) subjects with lateral
thoraco-lumbar spine radiographs available for evaluation
of vertebral height at the first visit were included in the
analysis. The subjects with spine radiographs had similar
clinical characteristics with those who did not have radio-
graphs at baseline (data not shown). The study protocol was
approved by the Institutional Review Board of the
University of Hong Kong and Hospital Authority Hong
Kong West Clustered Hospitals, and informed consent was
obtained from all participants according to the Declaration
of Helsinki.
Anthropometrical and other measurements
Baseline demographic data and clinical risk factors for
osteoporosis such as anthropometric measurements, socio-
economic status, education level, low-trauma fracture
history after the age of 45 years (both personal and family),
history of fall, medical history (including current medica-
tion, prior prescription of glucocorticoid and/or hormonal
therapy, history of thyroid or parathyroid disease, and
gastric or intestinal surgery), and reproductive history were
obtained at first visit. Additionally, information on lifestyle
habits including smoking and alcohol consumption were
also obtained at baseline. Dietary intake of calcium and
isoflavone was determined using a semiquantitative food
frequency questionnaire. These data were collected from
interviews conducted by a trained research assistant using a
structured questionnaire.
BMD measurements
Bone mineral density (BMD) of the L1 to L4 lumbar spine,
femoral neck, and total hip were determined using dual-energy
X-ray absortiometry (QDR-4500/DELPHI-W, Hologic Inc.,
Bedford, MA, USA) and by licensed technicians who were
accredited by the International Society for Clinical
Densitometry. The in vivo precision of the machine in
postmenopausal women is 1.2%, 1.5%, and 1.8% at the
lumbar spine, femoral neck, and total hip, respectively. The
peak young mean±SD BMD value used to calculate T-scores
for spine, femoral neck, and total hip, obtained from the local
Southern Chinese normative database [20], are 1.02±0.11,
0.77±0.09, and 0.86±0.10 g/cm2, respectively.
Vertebral morphometry
To compare the prevalence and risk factors for vertebral
fractures to US white and black women, thoracic and
lumbar spine lateral radiographs were taken according to
the quantitative procedures described by Black et al. [22].
Briefly, the heights of each vertebra (i.e., anterior (Ha),
middle (Hm), and posterior (Hp)) were measured by
placement of six points using a cursor and backlit digitizing
board. Vertebral morphometric fractures were defined using
ratios of vertebral height: the Ha/Hp (wedge) ratio, the Hm/Hp
ratio, and the ratio of posterior heights of adjacent vertebrae
Hpi/Hpi+1 and Hpi/Hpi−1 (crush). A vertebral body is
considered fractured when at least one of its ratios falls
below 3 SDs from normative mean values.
Statistical analyses
The baseline characteristics of Southern Chinese postmen-
opausal women who had a vertebral fracture were com-
pared with women who did not have a vertebral fracture
using t tests for continuous variables and χ2 tests for
categorical variables. Logistic regression models were
applied to determine the odds ratios (OR) of vertebral
fracture and the 95% CI for each SD decrease in BMD,
668 Osteoporos Int (2011) 22:667–674
Table 1 Baseline characteristics of postmenopausal women with and without prevalent vertebral fracture (n=1,372)
No vertebral fracture (n=1,073) Vertebral fracture (n=299)
Age (mean±SD) (year) 59.8±7.7 66±10.1*
Weight (mean±SD) (kg) 55.3±9.91 55.4±10.0
Height (mean±SD) (cm) 153.6±0.06 151.2±0.06**
Body mass index (mean±SD) (kg/m2) 23.1±3.4 24.2±3.9*
Age at menarche (mean±SD) (year) 13.9±2.0 14.7±2.2*
Age at menopause (mean±SD) (year) 49.5±3.9 49.7±4.3
Years since menopause (mean±SD) (year) 11.1±8.3 17.3±10.4**
Dietary calcium intake (mean±SD) (mg/day) 681.1±273.6 652.7±279.5
Dietary isoflavone intake (mean±SD) (mg/day) 25.4 ± 28.3 21.4±25.3
Age≥65 years 283 (26.4%) 163 (54.5%)**
BMI<19 26 (2.4%) 11 (3.7%)
Age at menarche>14 years 549 (51.2%) 196 (65.6%)**
Years since menopause >5 years 673 (62.7%) 234 (78.3%)**
Dietary calcium intake <400 mg/day 159 (14.8%) 53 (17.7%)
Dietary isoflavone intake <9.6 mg/day 350 (32.7%) 107 (35.8%)
Bilateral-oophorectomy 64 (6.0%) 17 (5.7%)
Current smoker or drinker 46 (4.3%) 22 (7.4%)*
Steroid use 5 (0.5%) 1 (0.3%)
Previous history of taking contraceptive pills 407 (37.9%) 84 (28.1%)*
Previous history of low back pain 568 (52.9%) 175 (58.7%)
Previous history of thyroid disease 54 (5.0%) 16 (5.4%)
Previous history of fracture after age of 45 yearsa 91 (8.5%) 79 (26.4%)**
Previous history of clinical spine fracture (self-reported) 0 (0%) 32 (10.7%)**
History of maternal fracture after age of 45 years 183 (17.1%) 29 (9.7%)**
≥1 fall in 12 months 168 (15.7%) 64 (21.4%)**
Walking<30 min/day 138 (12.9%) 43 (14.4%)
Any one site BMD T-score≤−2.5 244 (22.7%) 130 (43.6%)**
*p<0.05; **p<0.001
a Excluding clinical spine fracture
No vertebral fracture (n=1,073) Vertebral fracture (n=299)
Lumbar spine (L1–L4) T-scorea
Mean T-score (95% CI) −1.34 (−1.40, −1.27) −1.75 (−1.89, −1.61) **
T-score >−1 37.0%* 28.2% *
T-score <−1 and >−2.5 44.1%* 40.3%*
T-score ≤−2.5 17.1%* 31.2% *
Total hip T-scorea
Mean T-score (95% CI) −1.05 (−1.12, −0.99) −1.65 (−1.79, −1.52) *
T-score >−1 47.3%* 32.4% *
T-score <−1 and >−2.5 38.8%* 38.5%*
T-score ≤−2.5 11.2%* 28.5% *
Femoral neck T-scorea
Mean T-score (95% CI) −1.24 (−1.29, −1.18) −1.75 (−1.87, −1.64) **
T-score >−1 39.5%* 24.7% *
T-score <−1 and >−2.5 45.8%* 46.5%*
T-score ≤−2.5 13.4%* 27.8% *
Table 2 Comparison of bone
mineral density (BMD) between
postmenopausal women with
and without prevalent vertebral
fractures
t test for comparison of mean
T-score and ANOVA test for
category of T-score
*p<0.05; **p<0.001
a Local Southern Chinese norma-
tive database was used for calcu-
lation of T-scores
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bone mineral content (BMC), and bone mineral apparent
density (BMAD). The relationship between BMD and
prevalent vertebral fracture was determined using different
models with adjustment for age alone, age and body
weight, and a multivariable model of risk factors. Clinical
risk factors were included in the multivariable model if they
were associated with vertebral fractures (p≤0.1). In the
multivariable model, we adjusted for age (≥65 years), body
mass index (BMI<19 kg/m2), menarche age (>14 years),
years since menopause (>5 years), current smoker or
drinker, daily calcium intake (<400 mg/day), history of
fracture (excluding clinical spine fracture), and fall in the
last 12 months. To compare the discriminative value of
various measurements, we analyzed the areas under
receiver operating characteristic (ROC) curves using the C
statistics. Finally, the prevalence of vertebral fractures by
age and number of risk factors were determined. ROC
curve analysis was conducted using MedCalc package
version 9.3 (MedCalc, Mariakerke, Belgium). All statistical
analyses were performed using SPSS for Windows version
15.0 statistical software (SPSS, Chicago, IL, USA).
Results
Two hundred and ninety nine (22%) subjects were found to
have prevalent vertebral fractures. Table 1 summarizes the
baseline characteristics of the studied subjects. Compared
with women who did not have a prevalent vertebral
fracture, women with prevalent vertebral fractures were
older, had a later menarche age, had longer time since
menopause, and had a higher prevalence of smokers and
alcohol drinkers. Furthermore, these women were more
likely to fall during the previous 12 months, to fracture after
age of 45 years, to report clinical spine fracture, and to have
BMD T-score ≤−2.5 at anyone skeletal site. Interestingly,
Odds ratio 95% CI p
Age (every 5 years increase) 1.60 1.46–1.76 <0.0001
Height 0.86 0.83–0.97 <0.0001
Weight 0.97 0.95–0.98 0.001
Body mass index (treat as continuous variable) 1.05 1.01–1.09 0.006
Menarche age 1.20 1.12–1.30 <0.0001
Age at menopause 1.00 0.96–1.04 0.94
Years since menopause 1.08 1.06–1.10 <0.0001
Current smoker/drinker 1.99 1.19–3.33 0.008
Dietary calcium intake <400 mg/day 1.46 1.03–2.06 0.03
Dietary isoflavone intake <9.6 mg/day 1.15 0.88–1.50 0.30
Steroid use 1.41 0.16–12.1 0.75
Previous history of taking contraceptive pills 0.44 0.30–0.65 <0.0001
Previous history of thyroid disease 1.49 0.78–2.85 0.21
Previous history of fracture after age of 45 yearsa 3.80 2.77–5.41 <0.0001
History of maternal fracture after age of 45 years 1.23 0.52–1.88 0.46
1 or more falls in 12 months 3.27 2.29–4.65 <0.0001
Table 3 Risk factors for preva-
lent vertebral fractures based on
logistic regression model
a Excluded clinical vertebral
fracture
Table 4 Prevalence of one or more vertebral fracture according to the number of clinical risk factors and femoral neck BMD T-score
Prevalence of vertebral fracture Odds ratio (95% CI) p value
Number (%) (N=1,372)
Number of clinical risk factors
0–1 70/571 (12.3) Reference group
2–3 133/596 (22.3) 1.13 (0.77, 1.65) 0.54
≥4 96/205 (46.8) 2.26 (1.36, 3.73) <0.05
No. of clinical risk factors+femoral neck BMD T-score
0–1 Clinical risk factor+BMD T-score ≥−2.5 69/553 (12.5) Reference group
0–1 Clinical risk factor+BMD T-score <−2.5 1/18 (5.6) 0.37 (0.05, 2.80) 0.33
2–3 Clinical risk factors+BMD T-score <−2.5 25/96 (26.0) 1.00 (0.54, 1.87) 0.99
≥4 Clinical risk factors+BMD T-score <−2.5 56/102 (54.9) 2.64 (1.42, 4.91) <0.05
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women without vertebral fracture were more likely to have
a previous history of taking oral contraceptive pills.
Mean BMD T-score by prevalent vertebral fracture status
in Southern Chinese women is shown in Table 2. Subjects
with prevalent vertebral fractures had lower BMD values at
spine and hip. Using the local Southern Chinese normative
database, a significantly higher proportion of women with
prevalent vertebral fracture had BMD T-score of −2.5 or
less at any one skeletal site compared with those without
vertebral fracture. Indeed, the highest prevalence of
vertebral fractures was found in women with the lowest
tertiles of femoral neck BMD, BMC, and BMAD. Similar
results were obtained in the lumbar spine and total hip sites
(data not shown).
The clinical risk factors associated with vertebral
fractures in logistic regression were age, BMI, menarche
age, years since menopause, smoking or drinking, calcium
intake, fracture history, and fall in the last 12 months
(Table 3). The prevalence of vertebral fracture increased
markedly with increasing age and number of clinical risk
factors (Table 4 and Fig. 1). For example, the prevalence of
vertebral fractures in Southern Chinese women increased
sharply with age from 19% (88/459) between 60 and
69 years to 44% (89/204) between 70 and 79 years, to 68%
(30/44) for those ≥80 years. Additionally, the highest
prevalence of vertebral fractures was found in postmeno-
pausal women with four to eight clinical risk factors at
every 10-year age group (Fig. 1). Likewise, the prevalence
of vertebral fracture increased significantly with increasing
clinical risk factors from 12% with zero or one risk factor to
47% with four or more risk factors. Interestingly, adding
BMD T-score information did not alter the model signifi-
cantly (omnibus test p=0.081), suggesting that the addition
of BMD information did not improve the discrimination
ability of the model. For example, the odds for vertebral
fractures in women with four or more risk factors was 2.26
when compared with women who had the lowest risk (zero
to one risk factor) whereas women with a low BMD (T-
score ≤−2.5) and four or more risk factors had a similar
odds of 2.64, when compared with women who had the
lowest risk (BMD T-score >−2.5 and zero to one risk
factor) (Table 4).
In Hong Kong Southern Chinese postmenopausal women,
the odds of having a prevalent vertebral fracture per SD
reduction in BMD after adjustment for age was 1.51 (95% CI,
1.19, 1.90) for the lumbar spine and 1.52 (1.18, 1.98) for
femoral neck. Likewise, the odds ratio for vertebral fractures
for each SD reduction in BMC was 1.49 (1.17, 1.90) for the
lumbar spine and 1.51 (1.17, 1.94) for femoral neck.
Furthermore, the odds ratio for vertebral fractures for each
SD reduction in BMAD was 1.38 (1.07, 1.77) for femoral
neck (Table 5).
Analysis of ROC curves demonstrated that the area
under receiver operating characteristic curves (AUCs) for
BMD of the lumbar spine and femoral neck were 0.627 and
0.612, respectively, in Southern Chinese postmenopausal
women. Additional adjustment for body weight and other
risk factors had only a modest effect on the association
between BMD and prevalent vertebral fractures in Southern
Chinese postmenopausal women. Lastly, we found that
femoral neck BMAD did not improve the discrimination
ability for prevalence vertebral fracture when compared
with BMD.
Discussion
Prior vertebral fracture is a well-established independent
predictor of future osteoporotic fractures, including both
vertebral and nonvertebral fractures [24]. Majority of
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vertebral fractures are independent of falls and clinically
silent, and identification of subjects at risk of vertebral
fractures remains a clinical challenge. Using a cohort of
community-based population, we observed that the preva-
lence of vertebral fractures in Southern Chinese women
increased exponentially with age from 14% at ages
<60 years to 68% for women age 80 years and older,
confirming previous studies [25–29]. Age-specific preva-
lence of vertebral fractures in postmenopausal women have
been previously reported for several ethnic groups includ-
ing European women aged 50–79 years [27], US white
women aged 50 years and above [30], Taiwanese Chinese
women aged 40 years and above [19], and mainland
Chinese women from Beijing aged 50 and above [18],
and the prevalence of vertebral fractures is about 25% on
average in all these groups. In contrast to marked
worldwide variations in the prevalence of hip fractures,
we demonstrated that the prevalence of vertebral fractures
in Hong Kong Southern Chinese postmenopausal women is
22%, which is similar to that of the above-mentioned ethnic
groups. One possible reason for the ethnic variations in the
prevalence of hip fractures but not in vertebral fractures
may be due to the fact that hip fractures often associate with
falls, which in turn is associated with low body weight and
poor muscle strength, whereas the compression strength of
a vertebral body is largely determined by BMD [26].
This study failed to confirm maternal history of fracture as
a clinical risk factor. Significantly few women with
prevalent vertebral fractures had a positive maternal
history of fracture when compared with women without
prevalent vertebral fractures. Also, logistic regression did
not show a significant association between maternal
history of fracture and vertebral fracture prediction (p=
0.46). These conflicting results are likely due to missing
information on maternal history in a significant proportion
of subjects in this observational study.
It is well documented that low BMD, among all clinical
risk factors, is the major determinant of vertebral fracture.
We previously reported that after the adjustment for age and
BMI, the odds of having a vertebral fracture in Southern
Chinese women was 2.3 for each 1 SD reduction in spine
BMD and 2.1 for femoral neck BMD [20]. Data from the
present study revealed that women with prevalent vertebral
fractures had significantly lower BMD than those without
prevalent vertebral fractures. The odds of having a
prevalent vertebral fracture per SD reduction in BMD at
the spine and hip after adjustment for age was 1.5 This
findings are similar to the US white (OR=1.8) and black
women (OR=1.5–1.6) [23]. Furthermore, the ability in
discriminating prevalence vertebral fracture using BMD at
the spine and hip in Southern Chinese women is similar to
that of other ethnic groups (AUC=0.627 and 0.612 in
Southern Chinese, 0.660 and 0.672 in US white, and 0.660
and 0.655 in US black women at the spine and femoral
neck respectively) [23]. Likewise, the published Study of
Women’s Health Across the Nation (SWAN) have demon-
strated that BMD was comparable between Asian and
Caucasian women after adjustment for body size [31];
therefore, the similarity in the prevalence of vertebral
fracture in Southern Chinese and other ethnic groups seems
possible. It has been thought that BMAD would provide a
more accurate estimate of volumetric BMD because BMAD
would compensate for ethnic differences in bone size.
However, our results have demonstrated that BMAD did not
improve vertebral fracture risk prediction when compared
with BMD. The findings suggest that it is not necessary to use
BMAD clinically for fracture risk prediction.
Despite the similarities in the discriminating power
between the Southern Chinese model and the US white
Table 5 OR (95% CI) for prevalent vertebral fracture for 1 SD
decrease in BMD, BMC, or BMAD: age, age and body weight, and
multivariable-adjusted models in 1,372 Southern Chinese postmeno-
pausal women
Southern Chinese
OR (95% CI) AUC
Lumbar spine BMD
Age-adjusted 1.51 (1.19, 1.90) 0.627
Age and body weight 1.64 (1.26, 2.15) 0.635
Multivariatea 1.46 (1.11, 1.93) 0.700
Lumbar spine BMC
Age-adjusted 1.49 (1.17, 1.90) 0.631
Age and body weight 1.58 (1.21, 2.05) 0.636
Multivariatea 1.40 (1.06, 1.86) 0.699
Lumbar spine BMAD
Age-adjusted 1.39 (1.11, 1.75) 0.617
Age and body weight 1.45 (1.14, 1.86) 0.623
Multivariatea 1.39 (1.06, 1.81) 0.697
Femoral neck BMD
Age-adjusted 1.52 (1.18, 1.98) 0.612
Age and body weight 1.69 (1.26, 2.27) 0.628
Multivariatea 1.43 (1.05, 1.95) 0.692
Femoral neck BMC
Age adjusted 1.51 (1.17, 1.94) 0.612
Age and body weight 1.72 (1.28, 2.33) 0.623
Multivariatea 1.42 (1.04, 1.96) 0.698
Femoral neck BMAD
Age-adjusted 1.38 (1.07, 1.77) 0.597
Age and body weight 1.41 (1.08, 1.85) 0.603
Multivariatea 1.29 (0.97, 1.70) 0.683
a Hong Kong Southern Chinese aged 45 and above: multivariable model
includes adjustment for age, BMI, menarche age, years since menopause,
smoking or drinking, calcium intake, fracture history, fall in the last
12 months
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and black models using BMD as a discriminator, the
clinical risk factors identified were different between the
populations, suggesting the importance of population
characteristics and lifestyle factors in the pathogenesis of
osteoporotic fractures. Interestingly, evaluation of clinical
risk factors revealed that the addition of BMD to other
factors did not improve the discriminative ability in
identifying subjects with vertebral fractures. This observa-
tion suggested that clinical risk factors such as age, BMI,
menarche age, past history of fracture, and falls are
significant contributors to osteoporotic fracture risk over
that provided by BMD. The findings are in agreement with
previous reports of the World Health Organization algo-
rithms (FRAX®) for the 10-year absolute risk prediction
[32–34]; we found that the prevalence of vertebral fracture
was similar between those with or without the addition of
BMD T-score to the model. In view of the limited and
variable access to radiology investigations in most health
care systems in the world, a simple management scheme
using clinical risk factors to identify patients for further
evaluation would be a more practical approach in the
management of osteoporosis.
The present study has several strengths. First, a
community-based population was used to investigate the
prevalence of radiographic vertebral fractures. Second,
identical morphometric assessment methods and definitions
were adopted in this study for ease of comparison with data
derived from other studies [18, 23, 31]. However, one
major limitation of the study is that we did not examine the
whole cohort of HKOS study as only 1,372 (63%) subjects
had lateral spine radiographs at the first visit. Therefore, our
results may underestimate the true prevalence of vertebral
fractures in our population. Also, it is well established that
the shape of each vertebral level is unique, for example,
vertebrae in the mid thoracic spine and in the thoraco-
lumbar junction are slightly more wedged than other
regions of the spine. Using quantitative morphometric
approach to diagnose prevalent vertebral fractures may
have resulted in misinterpretation of normal variants as
mild vertebral deformities. Another drawback of the present
study is that our population is likely to have a different SD
on BMD, BMC, and BMAD than the Caucasian and black
women population in the study of Black et al. [23]. Also,
we used different risk factors in the multivariate models
from Black’s study. Due to the complexity of the differ-
ences between the two studies, our study should not be
used as a direct comparison to Black’s study. Despite these
limitations, our results could provide a reference on the
Southern Chinese women population. In conclusion, our
results demonstrated that the prevalence of vertebral
fracture increased exponentially with age and number of
clinical risk factors and decreasing BMD. Treatment of
women with asymptomatic vertebral fractures has been
shown to reduce future hip and vertebral fractures [35, 36]
and reduce disability [37]; since majority of vertebral
fractures are clinically silent, we recommend that case-
identification efforts should focus on older women with
multiple risk factors to identify women who are likely to
have a prevalent vertebral fracture.
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